BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 30140974)

  • 1. The Cross-Talk Between Sphingolipids and Insulin-Like Growth Factor Signaling: Significance for Aging and Neurodegeneration.
    Jęśko H; Stępień A; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 May; 56(5):3501-3521. PubMed ID: 30140974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.
    Loh KC; Baldwin D; Saba JD
    Anticancer Agents Med Chem; 2011 Nov; 11(9):782-93. PubMed ID: 21707493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Dependent Changes to Sphingolipid Balance in the Human Hippocampus are Gender-Specific and May Sensitize to Neurodegeneration.
    Couttas TA; Kain N; Tran C; Chatterton Z; Kwok JB; Don AS
    J Alzheimers Dis; 2018; 63(2):503-514. PubMed ID: 29660940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
    Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
    J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive sphingolipids in response to chemotherapy: a scope on leukemias.
    Ekiz HA; Baran Y
    Anticancer Agents Med Chem; 2011 May; 11(4):385-97. PubMed ID: 21453240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
    Van Brocklyn JR; Williams JB
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.
    Nikolova-Karakashian MN; Reid MB
    Antioxid Redox Signal; 2011 Nov; 15(9):2501-17. PubMed ID: 21453197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.
    Mignard V; Dubois N; Lanoé D; Joalland MP; Oliver L; Pecqueur C; Heymann D; Paris F; Vallette FM; Lalier L
    J Lipid Res; 2020 Jul; 61(7):1025-1037. PubMed ID: 32350079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
    Ayub M; Jin HK; Bae JS
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipids in cancer.
    Furuya H; Shimizu Y; Kawamori T
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):567-76. PubMed ID: 22005951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology.
    Tan-Chen S; Guitton J; Bourron O; Le Stunff H; Hajduch E
    Front Endocrinol (Lausanne); 2020; 11():491. PubMed ID: 32849282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the role of sphingolipids in cell survival and death.
    Iessi E; Marconi M; Manganelli V; Sorice M; Malorni W; Garofalo T; Matarrese P
    Int Rev Cell Mol Biol; 2020; 351():149-195. PubMed ID: 32247579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.